<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinmed</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical Medicine (Russian Journal)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0023-2149</issn><issn pub-type="epub">2412-1339</issn><publisher><publisher-name>ООО «Медицинское информационное агентство»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/0023-2149-2024-102-7-536-541</article-id><article-id custom-type="elpub" pub-id-type="custom">clinmed-883</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Значимость полиморфного варианта rs1050450 гена глутатионпероксидазы 1 в структуре факторов риска прогрессирования ишемической болезни сердца</article-title><trans-title-group xml:lang="en"><trans-title>The significance of the rs1050450 polymorphic variant of the glutathione peroxidase 1 gene in the structure of risk factors for the progression of coronary artery disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7361-2161</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Муслимова</surname><given-names>Э. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Muslimova</surname><given-names>E. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Муслимова Эльвира Фаритовна — канд. мед. наук, научный сотрудник лаборатории молекулярно-клеточной патологии и генодиагностики</p><p>Томск</p></bio><bio xml:lang="en"><p>Elvira F. Muslimova — Candidate of Medical Sciences, Researcher at the Laboratory of Molecular Cell Pathology and Genodiagnostics </p><p>Tomsk</p></bio><email xlink:type="simple">muslimovef@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3667-9599</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Реброва</surname><given-names>Т. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Rebrova</surname><given-names>T. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Реброва Татьяна Юрьевна — канд. мед. наук, научный сотрудник лаборатории молекулярно-клеточной патологии и генодиагностики</p><p>Томск</p></bio><bio xml:lang="en"><p>Tatyana Yu. Rebrova — Candidate of Medical Sciences, Researcher at the Laboratory of Molecular Cell Pathology and Genodiagnostics </p><p>Tomsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8070-2234</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кужелева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzheleva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кужелева Елена Андреевна — канд. мед. наук, старший научный сотрудник отделения патологии миокарда</p><p>Томск</p></bio><bio xml:lang="en"><p>Elena A. Kuzheleva — Candidate of Medical Sciences, Senior Researcher at the Department of Myocardial Pathology of the Cardiology Research Institute</p><p>Tomsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9488-6900</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гарганеева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Garganeeva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гарганеева Алла Анатольевна — д-р мед. наук, профессор, заведующая отделением патологии миокарда</p><p>Томск</p></bio><bio xml:lang="en"><p>Alla A. Garganeeva — Doctor of Medical Sciences, Professor, Head of the Department of Myocardial Pathology</p><p>Tomsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6066-3998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Афанасьев</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Afanasyev</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Афанасьев Сергей Александрович — д-р мед. наук, профессор, заведующий лаборатории молекулярно-клеточной патологии и генодиагностики</p><p>Томск</p></bio><bio xml:lang="en"><p>Sergey A. Afanasyev — Doctor of Medical Sciences, Professor, Head of the Laboratory of Molecular Cell Pathology and Genodiagnostics </p><p>Tomsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tomsk National Research Medical Center of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>21</day><month>11</month><year>2024</year></pub-date><volume>102</volume><issue>7</issue><fpage>536</fpage><lpage>541</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Муслимова Э.Ф., Реброва Т.Ю., Кужелева Е.А., Гарганеева А.А., Афанасьев С.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Муслимова Э.Ф., Реброва Т.Ю., Кужелева Е.А., Гарганеева А.А., Афанасьев С.А.</copyright-holder><copyright-holder xml:lang="en">Muslimova E.F., Rebrova T.Y., Kuzheleva E.A., Garganeeva A.A., Afanasyev S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinmedjournal.com/jour/article/view/883">https://www.clinmedjournal.com/jour/article/view/883</self-uri><abstract><p>Глутатионпероксидаза 1 (GPX1) играет важнейшую роль в блокировании участия окислительного стресса в формировании атеросклеротических бляшек. Известен полиморфный вариант rs1050450, который может быть связан с активностью фермента и тем самым влиять на прогрессирование ишемической болезни сердца (ИБС).</p><sec><title>Цель</title><p>Цель. Оценить связь варианта rs1050450 гена GPX1 с факторами риска прогрессирования ИБС: нарушениями углеводного обмена и концентрацией атерогенных фракций липопротеинов.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование вошли 168 пациентов с ИБС, из них 54,8% имели в анамнезе инфаркт миокарда (ИМ). Сахарный диабет выявлен у 29,8%, нарушение толерантности к глюкозе (НТГ) — у 10,1% пациентов. Определен вариант rs1050450 (Pro200Leu, 599C &gt; T) гена GPX1 с использованием TaqMan-зондов.</p></sec><sec><title>Результаты</title><p>Результаты. Гомозиготами CC были 141 пациент, гетерозиготами CT — 27 пациентов. Гомозиготы TT в выборке отсутствовали. Среди гетерозигот частота ИМ оказалась ниже, чем среди гомозигот CC — 37% против 58,2% (p = 0,043). У гетерозигот уровни общего холестерола и липопротеинов низкой плотности (ЛПНП) были ниже, чем у гомозигот: 3,8 (3,4; 4,5) против 4,3 (3,7;5,6) ммоль/л (p = 0,047) и 1,9 (1,4; 2,3) против 2,5 (1,9;3,3) ммоль/л (p = 0,005) соответственно. В то же время среди гетерозигот оказалась выше частота НТГ (22,2% против 7,8%, p = 0,023).</p></sec><sec><title>Заключение</title><p>Заключение. Среди больных ИБС носители генотипа CT варианта rs1050450 отличались меньшей частотой ИМ, но большей встречаемостью нарушений углеводного обмена. Гетерозиготы имели меньший уровень атерогенных ЛПНП и общего холестерина.</p></sec></abstract><trans-abstract xml:lang="en"><p>Glutathione peroxidase 1 (GPX1) plays a crucial role in blocking the involvement of oxidative stress in the formation of atherosclerotic plaques. A polymorphic variant rs1050450 is known, which may be associated with enzyme activity and thereby affect the progression of ischemic heart disease (IHD).</p><sec><title>Objective</title><p>Objective. To assess the association of the rs1050450 variant of the GPX1 gene with risk factors for the progression of IHD: carbohydrate metabolism disorders and the concentration of atherogenic lipoprotein fractions.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 168 patients with IHD, of whom 54.8% had a history of myocardial infarction (MI). Diabetes mellitus was identified in 29.8%, and glucose intolerance (GT) in 10.1% of patients. The rs1050450 variant (Pro200Leu, 599C &gt; T) of the GPX1 gene was determined using TaqMan probes.</p></sec><sec><title>Results</title><p>Results. There were 141 patients with CC homozygotes and 27 patients with CT heterozygotes. TT homozygotes were absent in the sample. Among heterozygotes, the frequency of MI was lower than among CC homozygotes—37% vs. 58.2% (p = 0.043). Heterozygotes had lower levels of total cholesterol and low-density lipoproteins (LDL) compared to homozygotes: 3.8 (3.4; 4.5) vs. 4.3 (3.7; 5.6) mmol/L (p = 0.047) and 1.9 (1.4; 2.3) vs. 2.5 (1.9; 3.3) mmol/L (p = 0.005), respectively. At the same time, the frequency of GT was higher among heterozygotes (22.2% vs. 7.8%, p = 0.023).</p></sec><sec><title>Conclusion</title><p>Conclusion. Among patients with IHD, carriers of the CT genotype of the rs1050450 variant showed a lower frequency of MI but a higher incidence of carbohydrate metabolism disorders. Heterozygotes had lower levels of atherogenic LDL and total cholesterol.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>липопротеины</kwd><kwd>общий холестерин</kwd><kwd>глютатионпероксидаза</kwd><kwd>GPX1</kwd><kwd>полиморфизм</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>нарушение толерантности к глюкозе</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lipoproteins</kwd><kwd>total cholesterol</kwd><kwd>glutathione peroxidase</kwd><kwd>GPX1</kwd><kwd>polymorphism</kwd><kwd>ischemic heart disease</kwd><kwd>glucose intolerance</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rebrova T.Y., Afanasiev S.A. State of the antioxidant system and the severity of lipid-peroxidation processes in the myocardium and blood plasma of rats of diff erent ages with postinfarction cardiosclerosis. Advances in Gerontology. 2021;2(11):152–157. DOI: 10.1134/S2079057021020132</mixed-citation><mixed-citation xml:lang="en">Rebrova T.Y., Afanasiev S.A. State of the antioxidant system and the severity of lipid-peroxidation processes in the myocardium and blood plasma of rats of diff erent ages with postinfarction cardiosclerosis. Advances in Gerontology. 2021;2(11):152–157. DOI: 10.1134/S2079057021020132</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Marchio P., Guerra-Ojeda S., Vila J., Aldasoro M., Victor V.M., Mauricio M.D. Targeting early atherosclerosis: A focus on oxidative stress and infl ammation. Oxid. Med. Cell. Longev. 2019;8563845. DOI: 10.1155/2019/8563845</mixed-citation><mixed-citation xml:lang="en">Marchio P., Guerra-Ojeda S., Vila J., Aldasoro M., Victor V.M., Mauricio M.D. Targeting early atherosclerosis: A focus on oxidative stress and infl ammation. Oxid. Med. Cell. Longev. 2019;8563845. DOI: 10.1155/2019/8563845</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Suzen H.S., Gucyener E., Sakalli O., Uckun Z., Kose G., Ustel D., Duydu Y. CAT C-262T and GPX1 Pro198Leu polymorphisms in a Turkish population. Mol. Biol. Rep. 2010;37:87–92. DOI: 10.1007/s11033-009-9540-4</mixed-citation><mixed-citation xml:lang="en">Suzen H.S., Gucyener E., Sakalli O., Uckun Z., Kose G., Ustel D., Duydu Y. CAT C-262T and GPX1 Pro198Leu polymorphisms in a Turkish population. Mol. Biol. Rep. 2010;37:87–92. DOI: 10.1007/s11033-009-9540-4</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lubos E., Loscalzo J., Handy D.E. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2011;7(15):1957–1997. DOI: 10.1089/ars.2010.3586</mixed-citation><mixed-citation xml:lang="en">Lubos E., Loscalzo J., Handy D.E. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2011;7(15):1957–1997. DOI: 10.1089/ars.2010.3586</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Волкова М.В., Рагино Ю.И. Современные биомаркеры окислительного стресса, оцениваемые методом иммуноферментного анализа. Атеросклероз. 2021;4(17):79–92. DOI: 10.52727/2078-256Х-2021-17-4-79-92</mixed-citation><mixed-citation xml:lang="en">Volkova M.V., Ragino Y.I. Modern biomarkers of oxidative stress estimated by immuno-enzymal analysis. Ateroscleroz. 2021;17(4):79–92. (In Russian)]. DOI: 10.52727/2078-256Х-2021-17-4-79-92</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hamanishi T., Furuta H., Kato H., Doi A., Tamai M., Shimomura H., Sakagashira S., Nishi M., Sasaki H., Sanke T., Nanjo K. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes. 2004;9(53):2455–2460. DOI: 10.2337/diabetes.53.9.2455</mixed-citation><mixed-citation xml:lang="en">Hamanishi T., Furuta H., Kato H., Doi A., Tamai M., Shimomura H., Sakagashira S., Nishi M., Sasaki H., Sanke T., Nanjo K. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes. 2004;9(53):2455–2460. DOI: 10.2337/diabetes.53.9.2455</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ravn-Haren G., Olsen A., Tjønneland A., Dragsted L.O., Nexø B.A., Wallin H., Overvad K., Raaschou-Nielsen O., Vogel U. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis. 2006;4(27):820–825.DOI: 10.1093/carcin/bgi267</mixed-citation><mixed-citation xml:lang="en">Ravn-Haren G., Olsen A., Tjønneland A., Dragsted L.O., Nexø B.A., Wallin H., Overvad K., Raaschou-Nielsen O., Vogel U. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis. 2006;4(27):820–825.DOI: 10.1093/carcin/bgi267</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Najafi M., Ghasemi H., Roustazadeh A., Farajollahi M. Lack of association between glutathione peroxidase1 (GPx1) activity, Pro198Leu polymorphism and stenosis of coronary arteries: A population-based prediction. Meta Gene. 2014;2:722–729. DOI: 10.1016/j.mgene.2014.09.007</mixed-citation><mixed-citation xml:lang="en">Najafi  M., Ghasemi H., Roustazadeh A., Farajollahi M. Lack of association between glutathione peroxidase1 (GPx1) activity, Pro198Leu polymorphism and stenosis of coronary arteries: A population-based prediction. Meta Gene. 2014;2:722–729. DOI: 10.1016/j.mgene.2014.09.007</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tarhonska K., Raimondi S., Specchia C., Wieczorek E., Reszka E., Krol M.B., Gromadzinska J., Wasowicz W., Socha K., Borawska M.H., Jablonska E. Association of allelic combinations in selenoprotein and redox related genes with markers of lipid metabolism and oxidative stress – multimarkers analysis in a crosssectional study. Journal of Trace Elements in Medicine and Biology. 2022;69:126873. DOI: 10.1016/j.jtemb.2021.126873</mixed-citation><mixed-citation xml:lang="en">Tarhonska K., Raimondi S., Specchia C., Wieczorek E., Reszka E., Krol M.B., Gromadzinska J., Wasowicz W., Socha K., Borawska M.H., Jablonska E. Association of allelic combinations in selenoprotein and redox related genes with markers of lipid metabolism and oxidative stress – multimarkers analysis in a crosssectional study. Journal of Trace Elements in Medicine and Biology. 2022;69:126873. DOI: 10.1016/j.jtemb.2021.126873</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yeh H.L., Kuo L.T., Sung F.C., Yeh C.C. Association between polymorphisms of antioxidant gene (MnSOD, CAT, and GPx1) and risk of coronary artery disease. Biomed. Res. Int. 2018;5086869. DOI: 10.1155/2018/5086869</mixed-citation><mixed-citation xml:lang="en">Yeh H.L., Kuo L.T., Sung F.C., Yeh C.C. Association between polymorphisms of antioxidant gene (MnSOD, CAT, and GPx1) and risk of coronary artery disease. Biomed. Res. Int. 2018;5086869. DOI: 10.1155/2018/5086869</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kuzuya M., Ando F., Iguchi A., Shimokata H. Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort. The American Journal of Clinical Nutrition. 2008;6(87):1939–1944. DOI: 10.1093/ajcn/87.6.1939</mixed-citation><mixed-citation xml:lang="en">Kuzuya M., Ando F., Iguchi A., Shimokata H. Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort. The American Journal of Clinical Nutrition. 2008;6(87):1939–1944. DOI: 10.1093/ajcn/87.6.1939</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Рекомендации по количественной оценке структуры и функции камер сердца. Российский кардиологический журнал. 2012;4(96) s4:1–27. DOI: 10.15829/1560-4071-2012-4s4</mixed-citation><mixed-citation xml:lang="en">Recommendations for quantifying the structure and function of the heart chambers. Russian Journal of Cardiology. 2012;4(96) s4:1–27. (In Russian)]. DOI: 10.15829/1560-4071-2012-4s4</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;11(25):311–374. DOI: 10.15829/1560-4071-2020-4083</mixed-citation><mixed-citation xml:lang="en">2020 Clinical practice guidelines for chronic heart failure. Russian Journal of Cardiology. 2020;11(25):311–374. (In Russian)]. DOI: 10.15829/1560-4071-2020-4083</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Buraczynska M., Buraczynska K., Dragan M., Ksiazek A. Pro198Leu polymorphism in the glutathione peroxidase 1 gene contributes to diabetic peripheral neuropathy in type 2 diabetes patients. Neuromol. Med. 2017;19:147–153. DOI: 10.1007/s12017-016-8438-2</mixed-citation><mixed-citation xml:lang="en">Buraczynska M., Buraczynska K., Dragan M., Ksiazek A. Pro198Leu polymorphism in the glutathione peroxidase 1 gene contributes to diabetic peripheral neuropathy in type 2 diabetes patients. Neuromol. Med. 2017;19:147–153. DOI: 10.1007/s12017-016-8438-2</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Куропаткина Т.А., Медведева Н.А., Медведев О.С. Роль селена в кардиологии. Кардиология. 2021;3(61):96–104. DOI: 10.18087/cardio.2021.3.n1186</mixed-citation><mixed-citation xml:lang="en">Kuropatkina T.A., Medvedeva N.A., Medvedev O.S. The role of selenium in cardiology. Kardiologiia. 2021;3(61):96–104. (In Russian)]. DOI: 10.18087/cardio.2021.3.n1186</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Afanasiev S.A., Garganeeva A.A., Kuzheleva E.A., Andriyanova A.V., Kondratieva D.S., Popov S.V. The impact of type 2 diabetes mellitus on long-term prognosis in patients of diff erent ages with myocardial infarction. Journal of Diabetes Research. 2018;1780683. DOI: 10.1155/2018/1780683</mixed-citation><mixed-citation xml:lang="en">Afanasiev S.A., Garganeeva A.A., Kuzheleva E.A., Andriyanova A.V., Kondratieva D.S., Popov S.V. The impact of type 2 diabetes mellitus on long-term prognosis in patients of diff erent ages with myocardial infarction. Journal of Diabetes Research. 2018;1780683. DOI: 10.1155/2018/1780683</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Garganeeva A.A., Kuzheleva E.A., Tukish O.V., Andreev S.L., Ogurkova O.N., Popov S.V. Prognostic value of type 2 diabetes mellitus and visfatin level in patients after coronary artery bypass grafting. Russian Open Medical Journal. 2023;12(2):205. DOI: 10.15275/rusomj.2023.0205</mixed-citation><mixed-citation xml:lang="en">Garganeeva A.A., Kuzheleva E.A., Tukish O.V., Andreev S.L., Ogurkova O.N., Popov S.V. Prognostic value of type 2 diabetes mellitus and visfatin level in patients after coronary artery bypass grafting. Russian Open Medical Journal. 2023;12(2):205. DOI: 10.15275/rusomj.2023.0205</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Liu D., Liu L., Hu Z., Song Z., Wang Y., Chen Z. Evaluation of the oxidative stress-related genes ALOX5, ALOX5AP, GPX1, GPX3 and MPO for contribution to the risk of type 2 diabetes mellitus in the Han Chinese population. Diab. Vasc. Dis. Res. 2018;15(4):336–339. DOI: 10.1177/1479164118755044</mixed-citation><mixed-citation xml:lang="en">Liu D., Liu L., Hu Z., Song Z., Wang Y., Chen Z. Evaluation of the oxidative stress-related genes ALOX5, ALOX5AP, GPX1, GPX3 and MPO for contribution to the risk of type 2 diabetes mellitus in the Han Chinese population. Diab. Vasc. Dis. Res. 2018;15(4):336–339. DOI: 10.1177/1479164118755044</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ensembl 2022. Nucleic Acids Research. 2022;50(D1):D988–D995. DOI: 10.1093/nar/gkab1049</mixed-citation><mixed-citation xml:lang="en">Ensembl 2022. Nucleic Acids Research. 2022;50(D1):D988–D995. DOI: 10.1093/nar/gkab1049</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
